Skip Navigation


JAC Advance Access originally published online on November 10, 2005
Journal of Antimicrobial Chemotherapy 2006 57(1):142-145; doi:10.1093/jac/dki389
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/1/142    most recent
dki389v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kassis-Chikhani, N.
Right arrow Articles by Arlet, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kassis-Chikhani, N.
Right arrow Articles by Arlet, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital

Najiby Kassis-Chikhani1,2, Dominique Decré3,*, Valérie Gautier3, Béatrice Burghoffer3, Faouzi Saliba4, Daniele Mathieu1, Didier Samuel4, Denis Castaing4, Jean-Claude Petit3, Elisabeth Dussaix1 and Guillaume Arlet3

1 Service de Microbiologie, Hôpital Paul Brousse, France; 2 Equipe Opérationnelle d'Hygiène, Hôpital Paul Brousse, France; 3 UPRES EA n°2392, Faculté de Médecine Saint Antoine, France; 4 Centre Hépato-Biliaire, Hôpital Paul Brousse, Assistance Publique—Hôpitaux de Paris, France

Received 24 August 2005; returned 26 September 2005; revised 28 September 2005; accepted 28 September 2005


* Correspondence address. Service de Bactériologie, Faculté de Médecine Saint Antoine, 27 rue Chaligny 75012 Paris, France. Tel: +33-1-40-01-14-46; Fax: +33-1-49-28-24-72; E-mail: dominique.decre{at}chusa.jussieu.fr

Objectives: We studied eight imipenem-resistant isolates of Klebsiella pneumoniae involved in an outbreak in a French teaching hospital.

Methods: The eight isolates were recovered from clinical specimens or rectal swabs. Antibiotic susceptibilities were determined using standard agar diffusion and dilution methods including synergy tests. PFGE was used to study the relatedness of isolates. Genes encoding ß-lactamases were characterized by transfer assays, specific amplification and cloning.

Results: The eight isolates were closely related by PFGE analysis and highly related to a K. pneumoniae strain from Greece. They were highly resistant to ß-lactams, including aztreonam and imipenem (MIC ≥32 mg/L), and were positive by the imipenem-EDTA disc synergy test. Isolates were also resistant to aminoglycosides, newer quinolones and sulfamethoxazole, and showed an intermediate level of resistance to tetracycline. VIM-1 and SHV-5 ß-lactamases were revealed in all isolates by PCR. The analysis of plasmid contents of Escherichia coli DH10B electroporants expressing the VIM-1 ß-lactamase or the SHV-5 ß-lactamase confirmed that the two enzymes were coded by two different plasmids. The blaVIM-1 gene was part of a class 1 integron that also included aac6, dhfrI and aadA genes and was similar to those reported from strains isolated in Greece.

Conclusions: This study confirms the potential risk of spread of multiresistant bacteria with international transfer of patients.

Keywords: imipenem resistance , class I integrons , liver transplants


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
G. M. Rossolini, F. Luzzaro, R. Migliavacca, C. Mugnaioli, B. Pini, F. De Luca, M. Perilli, S. Pollini, M. Spalla, G. Amicosante, et al.
First Countrywide Survey of Acquired Metallo-{beta}-Lactamases in Gram-Negative Pathogens in Italy
Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4023 - 4029.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. Psichogiou, P. T. Tassios, A. Avlamis, I. Stefanou, C. Kosmidis, E. Platsouka, O. Paniara, A. Xanthaki, M. Toutouza, G. L. Daikos, et al.
Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey
J. Antimicrob. Chemother., January 1, 2008; 61(1): 59 - 63.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. Colinon, V. Miriagou, A. Carattoli, F. Luzzaro, and G. M. Rossolini
Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 {beta}-lactamases
J. Antimicrob. Chemother., August 1, 2007; 60(2): 258 - 262.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
A. M. Queenan and K. Bush
Carbapenemases: the Versatile {beta}-Lactamases
Clin. Microbiol. Rev., July 1, 2007; 20(3): 440 - 458.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Ktari, G. Arlet, B. Mnif, V. Gautier, F. Mahjoubi, M. Ben Jmeaa, M. Bouaziz, and A. Hammami
Emergence of Multidrug-Resistant Klebsiella pneumoniae Isolates Producing VIM-4 Metallo-{beta}-Lactamase, CTX-M-15 Extended-Spectrum {beta}-Lactamase, and CMY-4 AmpC {beta}-Lactamase in a Tunisian University Hospital
Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4198 - 4201.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Loli, L. S. Tzouvelekis, E. Tzelepi, A. Carattoli, A. C. Vatopoulos, P. T. Tassios, and V. Miriagou
Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1
J. Antimicrob. Chemother., September 1, 2006; 58(3): 669 - 672.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.